The pioneers of the CRISPR gene-editing tool won a Nobel prize in 2020, and for good reason. The breakthrough has revolutionised biology, and is also transforming medicine and farming. Now, AI company ...

AI giant Anthropic has announced the discovery of a new enzyme system in bacterial DNA that it said could “represent a new gene editing mechanism” similar to the groundbreaking CRISPR tool. Anthropic ...

CRISPR may be a powerful technology for gene editing, but the system existed in bacteria long before scientists began using it. For billions of years, CRISPR has acted as a natural immune system in ...

A Cleveland Clinic first-in-human clinical trial has shown that a one-time infusion of a gene-editing therapy using CRISPR-Cas9 was effective and safe in reducing LDL ("bad") cholesterol and ...

It’s 7:35 a.m. inside Austin’s Fairmont Hotel when the elevator doors open and a fit, tanned man sporting a red-light therapy cap and yellow-tinted glasses steps into a packed, half-asleep car. “Are ...

From hyperbaric chambers to AI-enabled talking dolls, journalist Kara Swisher separates longevity fact from fad on her new CNN series Kara Swisher Wants to Live Forever. “There are all these ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that causes Down syndrome (DS). Down syndrome is a genetic condition caused by an ...

“Longevity” has become a replacement for “anti-ageing” in skincare, fueled by a consumer desire to optimise health rather than just fix wrinkles. Investments by beauty conglomerates and brand ...

Your responses may be used in an article that examines the growing popularity of biohacking. By Priya Krishna There’s a word that has become inescapable in recent years: biohacking. It refers to the ...

Please tell us what changes you’ve made to your health and wellness practices to improve your brain function and job performance. We may include your experiences in an article. By Noam Scheiber See ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...